A proposed model to study immunologic changes during chronic rhinosinusitis exacerbations: Data from a pilot study

Matthew A Rank, John B. Hagan, Shefali A. Samant, Hirohito Kita

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: One way to gain insight into the pathophysiology of chronic rhinosinusitis (CRS) is to study the immunologic changes that occur with exacerbation. This study describes the immunologic changes during CRS exacerbation Methods: We performed a prospective study to investigate the immunologic changes seen during exacerbation of CRS with nasal polyposis. We recruited adult subjects who met clinical criteria for CRS with sinus CT scan within the past 5 years with Lund-Mackay score of >5 and nasal polyps. Subjects underwent a baseline visit with collection of nasal secretion and nasal wash. With acute worsening of symptoms, subjects underwent 6 near-consecutive-day collections and one follow-up collection 2 weeks later. IL-6, IL-33, eosinophil major basic protein (MBP), eosinophil-derived neurotoxin (EDN), myeloperoxidase (MPO), and uric acid were measured on the nasal samples from each visit. Results: A total of 10 subjects were recruited and 9 had acute worsening of CRS during the study period. Eight of the nine subjects were women and ages ranged from 26 to 56 years. At baseline, most inflammatory parameters were low and eight of the nine subjects were on intranasal corticosteroids. Compared with baseline measurements, IL-6, MBP, MPO, EDN, and uric acid were significantly elevated during CRS exacerbation. Levels of IL-6 and MBP (r = 0.47) levels as well as IL-6 and MPO (r = 0.75) were both significantly correlated (p < 0.01). Conclusion: Prospective study of CRS exacerbations is feasible and provides insights into the immunologic mechanisms of CRS.

Original languageEnglish (US)
Pages (from-to)98-101
Number of pages4
JournalAmerican Journal of Rhinology and Allergy
Volume27
Issue number2
DOIs
StatePublished - Mar 2013

Fingerprint

Nose
Interleukin-6
Eosinophil-Derived Neurotoxin
Peroxidase
Uric Acid
Eosinophil Major Basic Protein
Prospective Studies
Nasal Polyps
Adrenal Cortex Hormones
Proteins

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Immunology and Allergy

Cite this

A proposed model to study immunologic changes during chronic rhinosinusitis exacerbations : Data from a pilot study. / Rank, Matthew A; Hagan, John B.; Samant, Shefali A.; Kita, Hirohito.

In: American Journal of Rhinology and Allergy, Vol. 27, No. 2, 03.2013, p. 98-101.

Research output: Contribution to journalArticle

@article{68bdcbd156204b7dab5506a156432ebe,
title = "A proposed model to study immunologic changes during chronic rhinosinusitis exacerbations: Data from a pilot study",
abstract = "Background: One way to gain insight into the pathophysiology of chronic rhinosinusitis (CRS) is to study the immunologic changes that occur with exacerbation. This study describes the immunologic changes during CRS exacerbation Methods: We performed a prospective study to investigate the immunologic changes seen during exacerbation of CRS with nasal polyposis. We recruited adult subjects who met clinical criteria for CRS with sinus CT scan within the past 5 years with Lund-Mackay score of >5 and nasal polyps. Subjects underwent a baseline visit with collection of nasal secretion and nasal wash. With acute worsening of symptoms, subjects underwent 6 near-consecutive-day collections and one follow-up collection 2 weeks later. IL-6, IL-33, eosinophil major basic protein (MBP), eosinophil-derived neurotoxin (EDN), myeloperoxidase (MPO), and uric acid were measured on the nasal samples from each visit. Results: A total of 10 subjects were recruited and 9 had acute worsening of CRS during the study period. Eight of the nine subjects were women and ages ranged from 26 to 56 years. At baseline, most inflammatory parameters were low and eight of the nine subjects were on intranasal corticosteroids. Compared with baseline measurements, IL-6, MBP, MPO, EDN, and uric acid were significantly elevated during CRS exacerbation. Levels of IL-6 and MBP (r = 0.47) levels as well as IL-6 and MPO (r = 0.75) were both significantly correlated (p < 0.01). Conclusion: Prospective study of CRS exacerbations is feasible and provides insights into the immunologic mechanisms of CRS.",
author = "Rank, {Matthew A} and Hagan, {John B.} and Samant, {Shefali A.} and Hirohito Kita",
year = "2013",
month = "3",
doi = "10.2500/ajra.2013.27.3850",
language = "English (US)",
volume = "27",
pages = "98--101",
journal = "American Journal of Rhinology and Allergy",
issn = "1945-8924",
publisher = "OceanSide Publications Inc.",
number = "2",

}

TY - JOUR

T1 - A proposed model to study immunologic changes during chronic rhinosinusitis exacerbations

T2 - Data from a pilot study

AU - Rank, Matthew A

AU - Hagan, John B.

AU - Samant, Shefali A.

AU - Kita, Hirohito

PY - 2013/3

Y1 - 2013/3

N2 - Background: One way to gain insight into the pathophysiology of chronic rhinosinusitis (CRS) is to study the immunologic changes that occur with exacerbation. This study describes the immunologic changes during CRS exacerbation Methods: We performed a prospective study to investigate the immunologic changes seen during exacerbation of CRS with nasal polyposis. We recruited adult subjects who met clinical criteria for CRS with sinus CT scan within the past 5 years with Lund-Mackay score of >5 and nasal polyps. Subjects underwent a baseline visit with collection of nasal secretion and nasal wash. With acute worsening of symptoms, subjects underwent 6 near-consecutive-day collections and one follow-up collection 2 weeks later. IL-6, IL-33, eosinophil major basic protein (MBP), eosinophil-derived neurotoxin (EDN), myeloperoxidase (MPO), and uric acid were measured on the nasal samples from each visit. Results: A total of 10 subjects were recruited and 9 had acute worsening of CRS during the study period. Eight of the nine subjects were women and ages ranged from 26 to 56 years. At baseline, most inflammatory parameters were low and eight of the nine subjects were on intranasal corticosteroids. Compared with baseline measurements, IL-6, MBP, MPO, EDN, and uric acid were significantly elevated during CRS exacerbation. Levels of IL-6 and MBP (r = 0.47) levels as well as IL-6 and MPO (r = 0.75) were both significantly correlated (p < 0.01). Conclusion: Prospective study of CRS exacerbations is feasible and provides insights into the immunologic mechanisms of CRS.

AB - Background: One way to gain insight into the pathophysiology of chronic rhinosinusitis (CRS) is to study the immunologic changes that occur with exacerbation. This study describes the immunologic changes during CRS exacerbation Methods: We performed a prospective study to investigate the immunologic changes seen during exacerbation of CRS with nasal polyposis. We recruited adult subjects who met clinical criteria for CRS with sinus CT scan within the past 5 years with Lund-Mackay score of >5 and nasal polyps. Subjects underwent a baseline visit with collection of nasal secretion and nasal wash. With acute worsening of symptoms, subjects underwent 6 near-consecutive-day collections and one follow-up collection 2 weeks later. IL-6, IL-33, eosinophil major basic protein (MBP), eosinophil-derived neurotoxin (EDN), myeloperoxidase (MPO), and uric acid were measured on the nasal samples from each visit. Results: A total of 10 subjects were recruited and 9 had acute worsening of CRS during the study period. Eight of the nine subjects were women and ages ranged from 26 to 56 years. At baseline, most inflammatory parameters were low and eight of the nine subjects were on intranasal corticosteroids. Compared with baseline measurements, IL-6, MBP, MPO, EDN, and uric acid were significantly elevated during CRS exacerbation. Levels of IL-6 and MBP (r = 0.47) levels as well as IL-6 and MPO (r = 0.75) were both significantly correlated (p < 0.01). Conclusion: Prospective study of CRS exacerbations is feasible and provides insights into the immunologic mechanisms of CRS.

UR - http://www.scopus.com/inward/record.url?scp=84876026514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876026514&partnerID=8YFLogxK

U2 - 10.2500/ajra.2013.27.3850

DO - 10.2500/ajra.2013.27.3850

M3 - Article

C2 - 23562196

AN - SCOPUS:84876026514

VL - 27

SP - 98

EP - 101

JO - American Journal of Rhinology and Allergy

JF - American Journal of Rhinology and Allergy

SN - 1945-8924

IS - 2

ER -